These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2826954)

  • 1. CY 208-243: a unique combination of atypical opioid antinociception and D1 dopaminomimetic properties.
    Foote RW; Büscher HH; Römer D; Maurer R; Enz A; Gähwiler BH; Shearman GT; Seiler MP; Wüthrich H
    Life Sci; 1988; 42(2):137-52. PubMed ID: 2826954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.
    Vonvoigtlander PF; Lewis RA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):259-62. PubMed ID: 2839665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors.
    Hynes MD; Lochner MA; Bemis KG; Hymson DL
    Life Sci; 1985 Jun; 36(24):2317-23. PubMed ID: 2989631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic and tolerance-inducing effects of the highly selective delta opioid agonist [D-Pen2,D-Pen5]enkephalin in mice.
    Kovács GL; Nyolczas N; Kriván M; Gulya K
    Eur J Pharmacol; 1988 Jun; 150(3):347-53. PubMed ID: 2843384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
    Karlsson G; Jaton AL; Vigouret JM
    Neurosci Lett; 1988 May; 88(1):69-74. PubMed ID: 2969468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antinociception with repeated microinjections of apomorphine into the periaqueductal gray of male and female rats.
    Schoo SM; Bobeck EN; Morgan MM
    Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):234-240. PubMed ID: 29256893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2001 Nov; 299(2):760-7. PubMed ID: 11602692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice.
    Abdelhamid EE; Takemori AE
    Eur J Pharmacol; 1991 Jun; 198(2-3):157-63. PubMed ID: 1650700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of eptazocine, a novel analgesic, with opioid receptors.
    Nabeshima T; Matsuno K; Kamei H; Kameyama T
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):173-81. PubMed ID: 2992058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
    Raffa RB; Friderichs E; Reimann W; Shank RP; Codd EE; Vaught JL
    J Pharmacol Exp Ther; 1992 Jan; 260(1):275-85. PubMed ID: 1309873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes.
    Kim DH; Fields HL; Barbaro NM
    Brain Res; 1990 May; 516(1):37-40. PubMed ID: 2163724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine tolerance does not develop in mice treated with endothelin-A receptor antagonists.
    Bhalla S; Matwyshyn G; Gulati A
    Brain Res; 2005 Dec; 1064(1-2):126-35. PubMed ID: 16289404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series.
    Fürst Z; Búzás B; Friedmann T; Schmidhammer H; Borsodi A
    Eur J Pharmacol; 1993 May; 236(2):209-15. PubMed ID: 8391457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists.
    Shippenberg TS; Herz A
    Brain Res; 1987 Dec; 436(1):169-72. PubMed ID: 2961413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys.
    Bowen CA; Fischer BD; Mello NK; Negus SS
    J Pharmacol Exp Ther; 2002 Jul; 302(1):264-73. PubMed ID: 12065726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effect of diisopropylphosphofluoridate: development of tolerance and lack of cross-tolerance to morphine.
    Costa LG; Murphy SD
    Neurobehav Toxicol Teratol; 1985; 7(3):251-6. PubMed ID: 2993935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
    France CP; Winger G; Medzihradsky F; Seggel MR; Rice KC; Woods JH
    J Pharmacol Exp Ther; 1991 Aug; 258(2):502-10. PubMed ID: 1650830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorespiratory effects of the novel opioid analgesic HP 736 in the anesthetized dog and conscious goat.
    Hubbard JW; Locke KW; Forster HV; Brice AG; Pan LG; Lowry TF; Forster AM; Forster MA; Cornfeldt M; Vanselous CL
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1268-77. PubMed ID: 1347566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.